Electrochemotherapy and its controversial results in patients with head and neck cancer

Anticancer Research

Volumn 34, Issue 2, 2014, Pages 967-972

  Seccia, Veronica ^a   Muscatello, Luca ^a   Dallan, Iacopo ^a   Bajraktari, Arisa ^a   Briganti, Tommaso ^a   Ursino, Stefano ^b   Galli, Luca ^a   Falcone, Alfredo ^a   Sellari franceschini, Stefano ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Bleomycin; Electrochemotherapy; Head and neck cancer; Palliation palliative care; Quality of life

Indexed keywords

BLEOMYCIN; KETOROLAC; MORPHINE; PARACETAMOL; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; AGED; ARTICLE; BLEEDING; BRACHYTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; DRUG PULSE THERAPY; DYSPHAGIA; ECCHYMOSIS; EDEMA; ELECTROCHEMOTHERAPY; ELECTROPORATION; FACE MALFORMATION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; POSTOPERATIVE PAIN; PULSE GENERATOR; QUALITY OF LIFE; RETROSPECTIVE STUDY; SUPERINFECTION; SWELLING; TRACHEOTOMY; TREATMENT RESPONSE; TRISMUS; ULCER; UNSPECIFIED SIDE EFFECT; VERY ELDERLY; HEAD AND NECK CANCER; HEAD AND NECK TUMOR; PALLIATION/PALLIATIVE CARE; PALLIATIVE THERAPY;

BLEOMYCIN; ELECTROCHEMOTHERAPY; HEAD AND NECK CANCER; PALLIATION/PALLIATIVE CARE; QUALITY OF LIFE;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; ELECTROCHEMOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 84897107896     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bloom DC and Goldfarb PM: The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 31: 1029-1035, 2005.
2. Testori A, Tosti G, Martinoli C, Spadola G, Cataldo F, Verrecchia F, Baldini F, Mosconi M, Soteldo J, Tedeschi I, Passoni C, Pari C, Di Pietro A and Ferrucci PF: Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach. Dermatol Ther 23: 651-661, 2010.
3. Campana LG, Valpione S, Mocellin S, Sundararajan R, Granziera E, Sartore L, Chiarion-Sileni V and Rossi CR: Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg 99: 821-830, 2012.
4. Landström FJ, Nilsson CO, Crafoord S, Reizenstein JA, Adamsson GB and Löfgren LA: Electroporation therapy of skin cancer in the head and neck area. Dermatol Surg 36: 1245-1250, 2010.
5. Jarm T, Cemazar M, Miklavcic D and Sersa G: Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 10: 729-746, 2010.
6. Gargiulo M, Papa A, Capasso P, Moio M, Cubicciotti E and Parascandolo S: Electrochemotherapy for non-melanoma head and neck cancers: Clinical outcomes in 25 patients. Ann Surg 255: 1158-1164, 2012.
7. Mir LM, Gehl J, Sersa G, Collins CG, Garbay J-R, Billard V, Geertsen PF, Rudolf Z, O'Sullivan GC and Marty M: Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or non-invasive electrodes. Eur J Cancer Supplements 4: 14-25, 2006.
8. Miklavcic D, Pucihar G, Pavlovec M, Ribaric S, Mali M, Macek-Lebar A, Petkovsek M, Nastran J, Kranjc S, Cemazar M and Sersa G: The effect of high frequency electric pulses on muscle contractions and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy. Bioelectrochemistry 65: 121-128, 2005.
9. Gothelf A, Mir LM and Gehl J: Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 29: 371-387, 2003.
10. Hofmann GA, Dev SB, Dimmer S and Nanda GS: Electroporation therapy: A new approach for the treatment of head and neck cancer. IEEE Trans Biomed Eng 46: 752-759, 1999.
11. Mali B, Jarm T, Snoj M, Sersa G and Miklavcic D: Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. Eur J Surg Oncol 39: 4-16, 2013.
12. Gargiulo M, Moio M, Monda G, Parascandolo S and Cubicciotti G: Electrochemotherapy: A ctual considerations and clinical experience in head and neck cancers. Ann Surg 251: 773, 2010.
13. Mevio N, Bertino G, Occhini A, Scelsi D, Tagliabue M, Mura F and Benazzo M: Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results. Tumori 98: 308-313, 2012.
14. Burian M, Formanek M, Regele H: Electroporation therapy in head and neck cancer. Acta Otolaryngol 123(2): 264-268, 2003.
15. Fantini F, Gualdi G, Cimitan A and Giannetti A: Metastatic basal cell carcinoma with squamous differentiation: report of a case with response of cutaneous metastases to electrochemotherapy. Arch Dermatol 144(9): 1186-1188, 2008.
16. WHO. National cancer control programs, policies and managerial guidelines. Second Edition. Geneva: World Health Organization, 2002.
17. Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME, Teknos TN, Wolf GT and Duffy SA: Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130(4): 401-408, 2004.